Journal of Virus Eradication (Jul 2019)
The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells
- G. Sampey,
- D. Irlbeck,
- E. Browne,
- M. Kanke,
- E. Cule,
- S. Wills,
- S. Falcinelli,
- Z. Wang,
- J. Kircherr,
- B. Allard,
- E. Stuelke,
- K. Sholtis,
- R. Ferris,
- J. Brehm,
- D. Favre,
- J.-P. Routy,
- C. Jones,
- N. Archin,
- D. Margolis,
- R. Dunham
Affiliations
- G. Sampey
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA; Qura Therapeutics, Chapel Hill, NC, USA
- D. Irlbeck
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA; ViiV Healthcare, Research Triangle Park, USA
- E. Browne
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA; Qura Therapeutics, Chapel Hill, NC, USA
- M. Kanke
- University of North Carolina at Chapel Hill, Departments of Biology and Genetics, Chapel Hill, NC, USA
- E. Cule
- GlaxoSmithKline, Research and Development, Stevenage, UK
- S. Wills
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA; Qura Therapeutics, Chapel Hill, NC, USA
- S. Falcinelli
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA
- Z. Wang
- GlaxoSmithKline, Research and Development, Collegeville, PA, USA
- J. Kircherr
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA
- B. Allard
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA
- E. Stuelke
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA
- K. Sholtis
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA
- R. Ferris
- ViiV Healthcare, Research Triangle Park, USA
- J. Brehm
- ViiV Healthcare, Research Triangle Park, USA
- D. Favre
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA
- J.-P. Routy
- McGill University Health Centre, Chronic Viral Infection Service and Division of Hematology, Montreal, Canada
- C. Jones
- University of North Carolina at Chapel Hill, Departments of Biology and Genetics, Chapel Hill, NC, USA
- N. Archin
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA
- D. Margolis
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA; Qura Therapeutics, Chapel Hill, NC, USA
- R. Dunham
- University of North Carolina at Chapel Hill, Dept of Medicine, UNC HIV Cure Center, Chapel Hill, NC, USA; Qura Therapeutics, Chapel Hill, NC, USA; ViiV Healthcare, Research Triangle Park, USA
- Journal volume & issue
-
Vol. 5
p. 14